Skip to main content
About Us
About Arcus
Leadership
Board of Directors
Scientific Advisory Board
Contact Us
Our Science
SEE PIPELINE
Discovery Candidates
Clinical Candidates
Anti-TIGIT
domvanalimab
AB308
Adenosine Pathway
etrumadenant
quemliclustat
Anti-PD1
zimberelimab
HIF-2⍺
AB521
Clinical Trials
Investigator Sponsored
Expanded Access Program
Publications
Editorials
Careers
Investors & Media
Press Releases
Events & Presentations
Events Calendar
Corporate Presentation
Stock Information
Analyst Coverage
Stock Information
SEC Filings
Corporate Governance
Governance Documents
Management Team
Board of Directors
Committee Composition
Contact Investor Relations
Contact Investor Relations
FAQs
Email Alerts
SEC Filings
About Us
About Arcus
Leadership
Board of Directors
Scientific Advisory Board
Contact Us
Our Science
SEE PIPELINE
Discovery Candidates
Clinical Candidates
Anti-TIGIT
domvanalimab
AB308
Adenosine Pathway
etrumadenant
quemliclustat
Anti-PD1
zimberelimab
HIF-2⍺
AB521
Clinical Trials
Investigator Sponsored
Expanded Access Program
Publications
Editorials
Careers
Investors & Media
Press Releases
Events & Presentations
Events Calendar
Corporate Presentation
Stock Information
Analyst Coverage
Stock Information
SEC Filings
Corporate Governance
Governance Documents
Management Team
Board of Directors
Committee Composition
Contact Investor Relations
Contact Investor Relations
FAQs
Email Alerts
Select Year:
Filter filing type:
All Forms
Annual Filings
Quarterly Filings
Current Reports
Proxy Filings
Registration Statements
Section 16 Filings
Other
Filing Type
Date
Description
Downloads